Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03298477 · ClinicalTrials.gov registry record · NA
EVAS2 IDE Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study
A NA study of Abdominal Aortic Aneurysm Without Rupture, sponsored by Endologix.
- Active
- Registry status
- NA
- Development phase
- 98
- Enrollment target
- 20
- Study locations
NCT03298477 is a NA study of Abdominal Aortic Aneurysm Without Rupture that is active but no longer recruiting, run by Endologix. The registered enrollment target is 98 participants. The trial reports 20 study locations across 15 states.
The verdict
NCT03298477, a NA study of Abdominal Aortic Aneurysm Without Rupture, is active but no longer recruiting, sponsored by Endologix.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 98 participants
- Enrollment target
- 20
- Study locations
Study Summary
Prospective, multicenter, single arm study with consecutive, eligible subject enrollment at each site. All subjects will undergo the Endovascular Aneurysm repair procedure with the Nellix System.
Conditions Studied
Interventions
- DEVICE Nellix® System
Study Locations (20)
Florida
- Miami Cardiac & Vascular Institute (MCVI) - Miami
- AdventHealth Orlando - Orlando
- Coastal Vascular & Interventional - Pensacola
California
- Regents of the University of California (UCLA) - Los Angeles
- Veterans Medical Research Foundation - San Diego
Illinois
- Christie Clinic - Champaign
- AMITA Health - Elk Grove Village
Ohio
- Cleveland Clinic - Cleveland
- Northeast Ohio Vascular Assoc (NEOVA) - Willoughby
Alabama
- Valley Vascular Consultants - Huntsville
Colorado
- UC Health-Memorial Hospital - Colorado Springs
District of Columbia
- MedStar Health Research Institute - Washington D.C.
Indiana
- St. Vincent Heart Center of Indiana - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2017-12-01 |
| Est. Completion | 2025-08-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03298477
The ClinicalTrials.gov registry entry for NCT03298477 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Endologix, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Abdominal Aortic Aneurysm Without Rupture appearing as the primary indexed condition, and to 1 intervention - of which Nellix® System is the first listed.
NCT03298477 reports 20 study locations spanning 15 distinct geographic areas - top geographies include Florida, California, Illinois.
Frequently Asked Questions
What is clinical trial NCT03298477 about?
NCT03298477 is a clinical study titled "EVAS2 IDE Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study". Prospective, multicenter, single arm study with consecutive, eligible subject enrollment at each site. All subjects will undergo the Endovascular Aneurysm repair procedure with the Nellix System.
What is the current status of trial NCT03298477?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 98 participants. The study started on 2017-12-01. Estimated completion is 2025-08-16.
What conditions does trial NCT03298477 study?
This clinical trial studies the following conditions: Abdominal Aortic Aneurysm Without Rupture.
What interventions are being tested in trial NCT03298477?
The interventions under investigation include: Nellix® System (DEVICE).
Who is sponsoring clinical trial NCT03298477?
This trial is sponsored by Endologix, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03298477 being conducted?
This trial has 20 study locations across Alabama, California, Colorado, District of Columbia, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.